Invited commentary on … Lithium treatment and risk for dementia in adults with bipolar disorder.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26135575.
- Also identified by DOI 10.1192/bjp.bp.114.161729.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alzheimer's disease clinical trials are failing at an alarming rate, highlighting the desperate need for novel thinking to combat this escalating health crisis. A recent large-scale population study indicates that lithium treatment reduces dementia development, supporting preclinical mechanistic evidence that this commonly used agent might be clinically valuable in dementia.
Medical subject headings
- Antimanic Agents
- Bipolar Disorder
- Dementia
- Lithium